| 000 | 01262 a2200313 4500 | ||
|---|---|---|---|
| 005 | 20250515043419.0 | ||
| 264 | 0 | _c20061205 | |
| 008 | 200612s 0 0 eng d | ||
| 022 | _a1007-9327 | ||
| 024 | 7 |
_a10.3748/wjg.v12.i38.6115 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _avan Bodegraven, A A | |
| 245 | 0 | 0 |
_aIndications for 5-aminosalicylate in inflammatory bowel disease: is the body of evidence complete? _h[electronic resource] |
| 260 |
_bWorld journal of gastroenterology _cOct 2006 |
||
| 300 |
_a6115-23 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review | ||
| 650 | 0 | 4 |
_aAdenocarcinoma _xprevention & control |
| 650 | 0 | 4 |
_aAnti-Inflammatory Agents, Non-Steroidal _xpharmacokinetics |
| 650 | 0 | 4 |
_aColonic Neoplasms _xprevention & control |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInflammatory Bowel Diseases _xdrug therapy |
| 650 | 0 | 4 |
_aMesalamine _xpharmacokinetics |
| 650 | 0 | 4 |
_aSulfasalazine _xtherapeutic use |
| 650 | 0 | 4 | _aTreatment Failure |
| 650 | 0 | 4 | _aTreatment Refusal |
| 700 | 1 | _aMulder, Chris J J | |
| 773 | 0 |
_tWorld journal of gastroenterology _gvol. 12 _gno. 38 _gp. 6115-23 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.3748/wjg.v12.i38.6115 _zAvailable from publisher's website |
| 999 |
_c16612648 _d16612648 |
||